921
Participants
Start Date
June 30, 2008
Primary Completion Date
July 31, 2011
Study Completion Date
February 28, 2014
Radium-223 dichloride (Xofigo, BAY88-8223)
Radium-223 dichloride 50 kBq/kg b.w., 6 IV administrations separated by 4 weeks intervals.
Placebo
Isotonic saline 6 IV administrations separated by 4 weeks intervals.
Best standard of care (BSoC)
Best standard of care is regarded as the routine standard of care at each center, for example local EBRT (External Beam Radiation Therapy), corticosteroids, antiandrogens, estrogens (e.g., stilboestrol), estramustine or ketoconazole.
Ottignies
Sydney
Randwick
St Leonards
Wahroonga
Liverpool
Wollongong
Fitzroy
Brisbane
Toowoomba
Adelaide
Adelaide
Bergen
Nedlands
Ålesund
Hobart
Trondheim
Bodø
Kortrijk
Tromsø
Candiolo
Berlin
Córdoba
Berlin
Santiago de Compostela
Milan
Hamburg
Bergamo
Montbéliard
Alcorcón
Hanover
Pamplona
Tampa
Marburg
Göttingen
Reggio Emilia
Dortmund
Valencia
Meldola
Barakaldo
Zaragoza
Mainz
Frankfurt am Main
St Louis
Brno
New Orleans
Sandviken
Bratislava
Bratislava
La Roche-sur-Yon
Ulm
Las Vegas
Saint-Cloud
Roseville
Banská Bystrica
Singapore
Singapore
Kfar Saba
Zrifin
Tel Aviv
Beersheba
Barretos
Belo Horizonte
Los Angeles
Philadelphia
Salvador
Belo Horizonte
Rio de Janeiro
Porto Alegre
Piracicaba
Chai Wan
Hong Kong
Kowloon
Cardiff
São Paulo
Edmonton
London
Ottawa
Toronto
Chomutov
Olomouc
Ostrava
Plzen - Bory
Prague
Ústí nad Labem
Alkmaar
Nijmegen
Rotterdam
Kristiansand
Oslo
Oslo
Bydgoszcz
Gliwice
Kielce
Krakow
Luiblin
Warsaw
Wroclaw
Wroclaw
Martin
Prešov
Trnava
Barcelona
Barcelona
Barcelona
Gothenburg
Jönköping
Kalmar
Malmo
Stockholm
Sundsvall
Umeå
Bristol
Romford
Leicester
Manchester
Bebington
Nottingham
Taunton
Ipswich
Guildford
Sutton
Coventry
Birmingham
Belfast
Brighton
Derby
Hull
Leeds
Northwood
Plymouth
Sheffield
Southampton
Wolverhampton
Lead Sponsor
Bayer
INDUSTRY